Page last updated: 2024-12-08

ios 11212

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2,6-dimethyl-3,5-bis(2'-propoxyethoxycarbonyl)-4-(2''-difluoromethoxyphenyl)-1,4-dihydropyridine: new Russian drug; corrector of acute transitory ischemia [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID159556
SCHEMBL ID195124
MeSH IDM0199517

Synonyms (16)

Synonym
118790-71-9
cerebrocrast
ios-1.1212
3,5-pyridinedicarboxylic acid, 1,4-dihydro-4-(2-(difluoromethoxy)phenyl)-2,6-dimethyl-, bis(2-propoxyethyl) ester
bis(2-propoxyethyl) 4-[2-(difluoromethoxy)phenyl]-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
ios 11212
2,6-dimethyl-3,5-bis(2'-propoxyethoxycarbonyl)-4-(2''-difluoromethoxyphenyl)-1,4-dihydropyridine
3,5-pyridinedicarboxylic acid, 4-(2-(difluoromethyl)phenyl)-1,4-dihydro-2,6-dimethyl-, bis(2-propoxyethyl) ester
108863-62-3
3,5-pyridinedicarboxylicacid, 4-[2-(difluoromethoxy)phenyl]-1,4-dihydro-2,6-dimethyl-,3,5-bis(2-propoxyethyl) ester
SCHEMBL195124
ios 1.1212
DTXSID70910889
bis(2-propoxyethyl) 4-(2-(difluoromethoxy)phenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
ascwbyzmmhuzmq-uhfffaoysa-n
AKOS040748107

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" The influence of the Ca(2+) channel antagonists on pancreatic beta cell functions is dependent on lipophilicity, interactions with the cell membrane lipid bilayer, with SNAREs protein complexes in cell and vesicle membranes, with intracellular receptors, bioavailability and time of elimination from several organs and the bloodstream."( Effect of new and known 1,4-dihydropyridine derivatives on blood glucose levels in normal and streptozotocin-induced diabetic rats.
Bisenieks, E; Briede, J; Duburs, G; Makarova, N; Poikāns, J; Stivriņa, M; Stoldere, D; Uldriķis, J,
)
0.13
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (23)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's8 (34.78)18.2507
2000's9 (39.13)29.6817
2010's6 (26.09)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.99

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.99 (24.57)
Research Supply Index3.43 (2.92)
Research Growth Index4.42 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.99)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other30 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]